Hestia Insight Inc. Stock

Equities

HSTA

US42815H1095

Diversified Investment Services

Market Closed - OTC Markets 13:57:24 2024-04-09 EDT 5-day change 1st Jan Change
0.177 USD +12.74% Intraday chart for Hestia Insight Inc. -.--% -29.20%
Sales 2022 0.02 0.02 Sales 2023 0.11 0.15 Capitalization 13.97M 19.06M
Net income 2022 -1M -1.36M Net income 2023 - 0 EV / Sales 2022 1,101,866,267 x
Net cash position 2022 515K 703K Net cash position 2023 167K 228K EV / Sales 2023 121,703,279 x
P/E ratio 2022
-9.94 x
P/E ratio 2023
-25 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 26.83%
More Fundamentals * Assessed data
Dynamic Chart
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023 CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023 CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023 CI
Hestia Insight Inc. entered into a Letter of Intent to acquire RecentCare Biomedical, Inc. CI
Hestia Insight Inc. signed letter of intent to acquire Prisma Biotech Corporation . CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 CI
Hestia Insight Inc. Auditor Raises 'Going Concern' Doubt CI
Hestia Insight Inc. Appoints T.Z. Chaung as Advisory Board Member CI
Hestia Insight Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022 CI
Hestia Insight Inc. Announces Advisory Board to Assist in Company Growth CI
Hestia Insight Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022 CI
Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022 CI
Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2021 CI
More news
1 day+12.74%
3 months-64.60%
6 months-64.60%
Current year-29.20%
More quotes
Current year
0.15
Extreme 0.15
1.02
1 year
0.15
Extreme 0.15
1.02
3 years
0.03
Extreme 0.03
6.96
5 years
0.03
Extreme 0.03
16.00
10 years
0.03
Extreme 0.03
145.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 71 19-03-05
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 67 22-01-03
Chief Executive Officer 71 19-03-05
More insiders
Hestia Insight Inc. is focused primarily on the healthcare and biotech sectors through its two wholly owned subsidiaries, Hestia Investments Inc. (Hestia Investments), and HSTA HEALTH INC., doing business as Hestia Vending (Hestia Vending). Hestia Investments provides strategic consulting, medical supply sales and marketing support, management, and capital markets advisory services for select micro, small and medium sized companies within the healthcare and biotech sectors. Hestia Vending operates within the healthy food, beverage and wellness products industry and the smart vending machine industry. It makes strategic acquisitions of emerging growth companies with sciences and technologies. It also intends to pursue the acquisition and development of healthcare related technologies in the healthcare and biotech sectors through acquisition, licensing or joint ventures. It also provides sales and marketing guidance and services and capital markets advisory services to its clients.
More about the company